3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Prostatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Waldenstrom Macroglobulinemia
1
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Precancerous Conditions
1
Polycystic Ovary Syndrome
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Prolymphocytic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Hodgkin Disease
1
Hemangioma, Cavernous, Central Nervous System
1
Heart Failure
1
Interventions
Tamoxifen
6
Radiotherapy
3
Anastrozole
3
Taxes
2
Simvastatin
2
Radiation
2
Paclitaxel
2
Neoadjuvant Therapy
2
Letrozole
2
Gene Expression Profiling
2
Chemotherapy, Adjuvant
2
Celecoxib
2
telapristone acetate
1
poly(I).poly(c12,U)
1
oxybutynin
1
liposomal doxorubicin
1
exemestane
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Yoga
1
Sugars
1
Sentinel Lymph Node Biopsy
1
Ranitidine
1
Radiation Dose Hypofractionation
1
Pharmacogenomic Testing
1
Naltrexone
1
Monitoring, Physiologic
1
Mometasone Furoate
1
Metformin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Breast Carcinoma In Situ
×
Atorvastatin
×
Clear all
No trials found.